chr12-45403426-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001025356.3(ANO6):c.1783-13T>C variant causes a intron change. The variant allele was found at a frequency of 0.0229 in 1,605,022 control chromosomes in the GnomAD database, including 695 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 43 hom., cov: 32)
Exomes 𝑓: 0.024 ( 652 hom. )
Consequence
ANO6
NM_001025356.3 intron
NM_001025356.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.61
Publications
2 publications found
Genes affected
ANO6 (HGNC:25240): (anoctamin 6) This gene encodes a multi-pass transmembrane protein that belongs to the anoctamin family. This protein is an essential component for the calcium-dependent exposure of phosphatidylserine on the cell surface. The scrambling of phospholipid occurs in various biological systems, such as when blood platelets are activated, they expose phosphatidylserine to trigger the clotting system. Mutations in this gene are associated with Scott syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011]
ANO6 Gene-Disease associations (from GenCC):
- Scott syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 12-45403426-T-C is Benign according to our data. Variant chr12-45403426-T-C is described in ClinVar as Benign. ClinVar VariationId is 257143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0668 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0167 AC: 2549AN: 152250Hom.: 42 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2549
AN:
152250
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0251 AC: 6288AN: 250856 AF XY: 0.0285 show subpopulations
GnomAD2 exomes
AF:
AC:
6288
AN:
250856
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0235 AC: 34161AN: 1452654Hom.: 652 Cov.: 30 AF XY: 0.0253 AC XY: 18272AN XY: 723316 show subpopulations
GnomAD4 exome
AF:
AC:
34161
AN:
1452654
Hom.:
Cov.:
30
AF XY:
AC XY:
18272
AN XY:
723316
show subpopulations
African (AFR)
AF:
AC:
135
AN:
33260
American (AMR)
AF:
AC:
469
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
461
AN:
26072
East Asian (EAS)
AF:
AC:
9
AN:
39626
South Asian (SAS)
AF:
AC:
6007
AN:
86048
European-Finnish (FIN)
AF:
AC:
1444
AN:
53352
Middle Eastern (MID)
AF:
AC:
297
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
24024
AN:
1103764
Other (OTH)
AF:
AC:
1315
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1790
3580
5370
7160
8950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0167 AC: 2552AN: 152368Hom.: 43 Cov.: 32 AF XY: 0.0173 AC XY: 1290AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
2552
AN:
152368
Hom.:
Cov.:
32
AF XY:
AC XY:
1290
AN XY:
74518
show subpopulations
African (AFR)
AF:
AC:
122
AN:
41580
American (AMR)
AF:
AC:
182
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
66
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5196
South Asian (SAS)
AF:
AC:
353
AN:
4830
European-Finnish (FIN)
AF:
AC:
244
AN:
10624
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1515
AN:
68038
Other (OTH)
AF:
AC:
34
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
127
253
380
506
633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
76
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.